Convalescent plasma therapy and long-term SARS-COV-2 antiviral immune response in a prospective cohort of patients with COVID-19

During the SARS-CoV-2 pandemic, the use of convalescent plasma (CP) in high-risk patients was proposed and widely implemented in several countries as a potential COVID-19 therapy. Nonetheless, CP therapy’s impact on immune response is nowadays poorly understood, including the correlation between IgG...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Aldo Barrera, Constanza Martínez-Valdebenito, Bruno Nervi, Aracelly Gaete-Argel, Nicolás M.S. Gálvez, Catalina Osses, Cecilia Vizcaya, María E. Ceballos, Jaime Pereira, Mayling Chang, Luis Rojas, Sebastián Mondaca, Carolina Henríquez, Alexis M. Kalergis, Alessandro Sette, Alba Grifoni, Ricardo Soto-Rifo, Fernando Valiente-Echeverría, Marcela Ferres, María E. Balcells, Nicole Le Corre
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2025-01-01
Schriftenreihe:	Current Research in Microbial Sciences
Schlagworte:	SARS-CoV-2 COVID-19 Convalescent plasma Immune response
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2666517425001014
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!